ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
Development of a 3D Human Colon Model Along with Bioelectronics for the Induction and Monitoring of Diseases.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development of a 3D Human Colon Model Along with Bioelectronics for the Induction and Monitoring of Diseases.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Conventional in vitro and animal models do not reproduce the geometry, mechanics, or transport physics of the human colon, limiting their fidelity for disease studies and drug screening. A patient-derived, freeform reversible embedding of suspended hydrogels bioprinted three-dimensional (3D) in vivo mimicking human-colon model (3D-IVM-HC) is reported whose micro-computed tomography (CT) profile deviates by less than 4% from the original computed tomography template and spontaneously forms crypt-like invaginations with a median depth of 65 µm. The dual-layer gelatin methacrylate (GelMA)/alginate matrix matches native colonic stiffness (9-65 kPa) and sustains >95% cell viability with a 14-fold metabolic increase over 14 days. Caco-2 epithelia polarize within the lumen, form continuous Zonula occludens-1 (ZO-1) belts, and reach a transepithelial electrical resistance (TEER) of 68 ± 4 Ω cm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.